Product

Company

NCT06980649·18 sites·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Biohaven Therapeutics Ltd.

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

1. History of hyperthyroidism not caused by Graves' Disease (e.g., toxic adenoma or toxic multinodular goiter) and/or history of thyroid storm within six weeks of the Baseline visit.
2. History of treatment with radioactive iodine or thyroid surgery.

The record

StatusRecruiting

PhasePhase 1

Taking part15

StartedAug 2025

UpdatedJul 31, 2026

Conditions

Where18

Clareo Health | Study of BHV-1300 in Graves' Disease